Variant report
Variant | esv2560297 |
---|---|
Chromosome Location | chr12:75110363-75116875 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:75106983..75109185-chr12:75115008..75117745,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7955185 | chr12:75110427-75110428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113873573 | chr12:75110484-75110485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368980099 | chr12:75110564-75110565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570772560 | chr12:75110569-75110570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60341073 | chr12:75110570-75110571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs556455262 | chr12:75110591-75110592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115461153 | chr12:75110595-75110596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73359998 | chr12:75110596-75110597 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554644281 | chr12:75110604-75110605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574487273 | chr12:75110639-75110640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540194905 | chr12:75110681-75110682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554123536 | chr12:75110709-75110710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577181097 | chr12:75110759-75110760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149381211 | chr12:75110764-75110765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79331670 | chr12:75110794-75110795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78074389 | chr12:75110795-75110796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566033475 | chr12:75110859-75110860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7958512 | chr12:75110860-75110861 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs189727069 | chr12:75110871-75110872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527691285 | chr12:75110930-75110931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547354476 | chr12:75110944-75110945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570833942 | chr12:75110955-75110956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79685719 | chr12:75110973-75110974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7971770 | chr12:75110982-75110983 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs192706994 | chr12:75111058-75111059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78066052 | chr12:75111075-75111076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141854334 | chr12:75111123-75111124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs59792000 | chr12:75111170-75111171 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs554714748 | chr12:75111173-75111174 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568127807 | chr12:75111194-75111195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61932625 | chr12:75111217-75111218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553830085 | chr12:75111249-75111250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576893407 | chr12:75111320-75111321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7972303 | chr12:75111321-75111322 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs556419420 | chr12:75111333-75111334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143695074 | chr12:75111345-75111346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541970163 | chr12:75111356-75111357 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561865001 | chr12:75111415-75111416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75228340 | chr12:75111527-75111528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527754391 | chr12:75111543-75111544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541107854 | chr12:75111570-75111571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564178253 | chr12:75111615-75111616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10879828 | chr12:75111646-75111647 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs550208303 | chr12:75111664-75111665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563966934 | chr12:75111665-75111666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529478435 | chr12:75111668-75111669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78734799 | chr12:75111669-75111670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12366985 | chr12:75111676-75111677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200278909 | chr12:75111677-75111678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183484419 | chr12:75111685-75111686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 17133270 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:75110400-75110800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr12:75110400-75110800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr12:75110800-75111400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr12:75110800-75116600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
5 | chr12:75115000-75116800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr12:75115800-75116200 | Enhancers | Left Ventricle | heart |
7 | chr12:75115800-75116400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr12:75116000-75116200 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr12:75116000-75116400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr12:75116000-75116400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr12:75116400-75117000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr12:75116400-75117400 | Weak transcription | H9 Cell Line | embryonic stem cell |
13 | chr12:75116400-75117400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr12:75116600-75118000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |